Abstract
Lung cancer is a major global health problem. Image-guided radiation therapy (IGRT), including stereotactic body radiation therapy and adaptive radiation therapy, is emerging as an important technique to try and deliver precise high-dose radiation to the tumor volume while minimizing dose to the normal structures. This chapter intends to highlight some of the features of IGRT including simulation for treatment planning, immobilization devices, target delineation for IGRT, setup and image verification, treatment delivery, radiobiology and physics considerations, clinical outcomes, and ongoing research.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108.
American Cancer Society. Global cancer facts and figures. Atlanta: American Cancer Society; 2007.
Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225–49.
Le Chevalier T, Arriagada R, Quoix E, et al. Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. J Natl Cancer Inst. 1991;83:417–23.
Bradley J, Graham MV, Winter K, et al. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma. Int J Radiat Oncol Biol Phys. 2005;61:318–28.
Rosenzweig KE, Fox JL, Yorke E, et al. Results of a phase I dose-escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable nonsmall cell lung carcinoma. Cancer. 2005;103:2118–27.
Hayman JA, Martel MK, Ten Haken RK, et al. Dose escalation in non-small-cell lung cancer using three-dimensional conformal radiation therapy: update of a phase I trial. J Clin Oncol. 2001;19:127–36.
Kong FM, Hayman JA, Griffith KA, et al. Final toxicity results of a radiation-dose escalation study in patients with non-small-cell lung cancer (NSCLC): predictors for radiation pneumonitis and fibrosis. Int J Radiat Oncol Biol Phys. 2006;65:1075–86.
Sura S, Gupta V, Yorke E, et al. Intensity-modulated radiation therapy (IMRT) for inoperable non-small cell lung cancer: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience. Radiother Oncol. 2008;87:17–23.
Liao ZX, Komaki RR, Thames Jr HD, et al. Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy. Int J Radiat Oncol Biol Phys. 2009;76(3):775–81.
Gould MK, Maclean CC, Kuschner WG, et al. Accuracy of positron emission tomography for diagnosis of pulmonary nodules and mass lesions: a meta-analysis. JAMA. 2001;285:914–24.
Toloza EM, Harpole L, Detterbeck F, et al. Invasive staging of non-small cell lung cancer: a review of the current evidence. Chest. 2003;123:157S–66.
Gould MK, Kuschner WG, Rydzak CE, et al. Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: a meta-analysis. Ann Intern Med. 2003;139:879–92.
Reed CE, Harpole DH, Posther KE, et al. Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J Thorac Cardiovasc Surg. 2003;126:1943–51.
Bentel GC, Marks LB, Krishnamurthy R. Impact of cradle immobilization on setup reproducibility during external beam radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys. 1997;38:527–31.
Baba F, Shibamoto Y, Tomita N, et al. Stereotactic body radiotherapy for stage I lung cancer and small lung metastasis: evaluation of an immobilization system for suppression of respiratory tumor movement and preliminary results. Radiat Oncol. 2009;4:15.
Fox T, Elder E, Crocker I. Image registration and fusion techniques. In: Paulino AC, Teh BS, editors. PET-CT in radiotherapy treatment planning. Philadelphia: Saunders/Elsevier; 2008.
Paulino AC, Johnstone PA. FDG-PET in radiotherapy treatment planning: Pandora’s box? Int J Radiat Oncol Biol Phys. 2004;59:4–5.
Nestle U, Kremp S, Schaefer-Schuler A, et al. Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-Small cell lung cancer. J Nucl Med. 2005;46:1342–8.
Liu BJ, Dong JC, Xu CQ, et al. Accuracy of 18F-FDG PET/CT for lymph node staging in non-small-cell lung cancers. Chin Med J (Engl). 2009;122:1749–54.
Munley MT, Marks LB, Scarfone C, et al. Multimodality nuclear medicine imaging in three-dimensional radiation treatment planning for lung cancer: challenges and prospects. Lung Cancer. 1999;23:105–14.
Deniaud-Alexandre E, Touboul E, Lerouge D, et al. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2005;63:1432–41.
Bradley J, Thorstad WL, Mutic S, et al. Impact of FDG-PET on radiation therapy volume delineation in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2004;59:78–86.
Bradley JD, Bae K, Choi N, et al. A phase II comparative study of Gross tumor volume definition with or without PET/CT fusion in dosimetric planning for non–small-cell lung cancer (NSCLC): primary analysis of Radiation Therapy Oncology Group (RTOG) 0515. Int J Radiat Oncol Biol Phys. 2009;75:S2.
Jin JY, Ajlouni M, Chen Q, et al. A technique of using gated-CT images to determine internal target volume (ITV) for fractionated stereotactic lung radiotherapy. Radiother Oncol. 2006;78:177–84.
Underberg RW, Lagerwaard FJ, Cuijpers JP, et al. Four-dimensional CT scans for treatment planning in stereotactic radiotherapy for stage I lung cancer. Int J Radiat Oncol Biol Phys. 2004;60:1283–90.
Underberg RW, Lagerwaard FJ, Slotman BJ, et al. Use of maximum intensity projections (MIP) for target volume generation in 4DCT scans for lung cancer. Int J Radiat Oncol Biol Phys. 2005;63:253–60.
Droege RT, Bjarngard BE. Influence of metal screens on contrast in megavoltage x-ray imaging. Med Phys. 1979;6:487–93.
Droege RT, Bjarngard BE. Metal screen-film detector MTF at megavoltage x-ray energies. Med Phys. 1979;6:515–8.
Antonuk LE, El-Mohri Y, Huang W, et al. Initial performance evaluation of an indirect-detection, active matrix flat-panel imager (AMFPI) prototype for megavoltage imaging. Int J Radiat Oncol Biol Phys. 1998;42:437–54.
Ma CM, Paskalev K. In-room CT techniques for image-guided radiation therapy. Med Dosim. 2006;31:30–9.
Kuriyama K, Onishi H, Sano N, et al. A new irradiation unit constructed of self-moving gantry-CT and linac. Int J Radiat Oncol Biol Phys. 2003;55:428–35.
Feldkamp IA, Davis LC, Kress JW. Practical cone-beam algorithm. J Opt Soc Am A. 1984;1:612–9.
Jaffray DA, Siewerdsen JH, Wong JW, et al. Flat-panel cone-beam computed tomography for image-guided radiation therapy. Int J Radiat Oncol Biol Phys. 2002;53:1337–49.
Morin O, Gillis A, Chen J, et al. Megavoltage cone-beam CT: system description and clinical applications. Med Dosim. 2006;31:51–61.
Khan FM. The physics of radiation therapy. 3rd ed. Philadelphia: Lippincott Williams & Wilkins; 2009.
Mackie TR, Holmes T, Swerdloff S, et al. Tomotherapy: a new concept for the delivery of dynamic conformal radiotherapy. Med Phys. 1993;20:1709–19.
Zhou J, Uhl B, Dewitt K, et al. Image-guided stereotactic body radiotherapy for lung tumors using bodyloc with tomotherapy: clinical implementation and set-up accuracy. Med Dosim. 2010;35(1):12–8. doi: 10.1016/j.meddos.2008.12.003. Epub 2009 Jan 30.
Jin JY, Yin FF, Tenn SE, et al. Use of the BrainLAB ExacTrac X-Ray 6D system in image-guided radiotherapy. Med Dosim. 2008;33:124–34.
Chang Z, Wang Z, Wu QJ, et al. Dosimetric characteristics of novalis Tx system with high definition multileaf collimator. Med Phys. 2008;35:4460–3.
Walls NM, Nurushev T, Jin JY, et al. Assessment of 2D X-ray and volumetric-based localization imaging for patients treated with SRS and SBRT. Int J Radiat Oncol Biol Phys. 2009;75:S-682.
Adler Jr JR, Chang SD, Murphy MJ, et al. The Cyberknife: a frameless robotic system for radiosurgery. Stereotact Funct Neurosurg. 1997;69:124–8.
Fu D, Kuduvalli G. A fast, accurate, and automatic 2D-3D image registration for image-guided cranial radiosurgery. Med Phys. 2008;35:2180–94.
Fu D, Kuduvalli G. Enhancing skeletal features in digitally reconstructed radiographs. In: Reinhardt JM, Pluim JP, editors. Medical imaging 2006: image processing. Vol 6144. San Diego: The International Society for Optical Engineering; 2006. p. Abstract 61442 M.
Fu D, Kuduvalli G, Maurer CJ, et al. 3D target localization using 2D local displacements of skeletal structures in orthogonal x-ray images for image-guided spinal radiosurgery. Int J CARS. 2006;1:198–200.
Ho AK, Fu D, Cotrutz C, et al. A study of the accuracy of cyberknife spinal radiosurgery using skeletal structure tracking. Neurosurgery. 2007;60:ONS147–56. discussion ONS156.
Mu Z, Fu D, Kuduvally G. Multiple fiducial identification using the hidden Markov model in image guided radiosurgery. In: Proceedings of the conference on computer vision and pattern recognition workshop: IEEE. New York, June 17–22, 2006; pp. 0-7695-2646-7692/7606.
Murphy MJ. Fiducial-based targeting accuracy for external-beam radiotherapy. Med Phys. 2002;29:334–44.
Chuang CF, Larson DA, Zytkovicz A, et al. Peripheral dose measurement for CyberKnife radiosurgery with upgraded linac shielding. Med Phys. 2008;35:1494–6.
Kothary N, Heit JJ, Louie JD, et al. Safety and efficacy of percutaneous fiducial marker implantation for image-guided radiation therapy. J Vasc Interv Radiol. 2009;20:235–9.
Kothary N, Dieterich S, Louie JD, et al. Percutaneous implantation of fiducial markers for imaging-guided radiation therapy. AJR Am J Roentgenol. 2009;192:1090–6.
West JB, Fitzpatrick JM, Toms SA, et al. Fiducial point placement and the accuracy of point-based, rigid body registration. Neurosurgery. 2001;48:810–6. discussion 816–817.
Mitchell H, Newton I. Medical photogrammetric measurement: overview and prospects. ISPRS J Photogramm. 2002;56:286–94.
Yan D, Vicini F, Wong J, et al. Adaptive radiation therapy. Phys Med Biol. 1997;42:123–32.
Yan D, Wong J, Vicini F, et al. Adaptive modification of treatment planning to minimize the deleterious effects of treatment setup errors. Int J Radiat Oncol Biol Phys. 1997;38:197–206.
Kupelian PA, Ramsey C, Meeks SL, et al. Serial megavoltage CT imaging during external beam radiotherapy for non-small-cell lung cancer: observations on tumor regression during treatment. Int J Radiat Oncol Biol Phys. 2005;63:1024–8.
Ramsey CR, Langen KM, Kupelian PA, et al. A technique for adaptive image-guided helical tomotherapy for lung cancer. Int J Radiat Oncol Biol Phys. 2006;64:1237–44.
Bissonnette JP, Purdie TG, Higgins JA, et al. Cone-beam computed tomographic image guidance for lung cancer radiation therapy. Int J Radiat Oncol Biol Phys. 2009;73:927–34.
Onishi H, Araki T, Shirato H, et al. Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multiinstitutional study. Cancer. 2004;101:1623–31.
Guckenberger M, Wulf J, Mueller G, et al. Dose–response relationship for image-guided stereotactic body radiotherapy of pulmonary tumors: relevance of 4D dose calculation. Int J Radiat Oncol Biol Phys. 2009;74:47–54.
Kirkpatrick JP, Meyer JJ, Marks LB. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Semin Radiat Oncol. 2008;18:240–3.
Fuks Z, Kolesnick R. Engaging the vascular component of the tumor response. Cancer Cell. 2005;8:89–91.
Garcia-Barros M, Paris F, Cordon-Cardo C, et al. Tumor response to radiotherapy regulated by endothelial cell apoptosis. Science. 2003;300:1155–9.
Brenner DJ. The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Semin Radiat Oncol. 2008;18:234–9.
Milano MT, Constine LS, Okunieff P. Normal tissue toxicity after small field hypofractionated stereotactic body radiation. Radiat Oncol. 2008;3:36.
Park C, Papiez L, Zhang S, et al. Universal survival curve and single fraction equivalent dose: useful tools in understanding potency of ablative radiotherapy. Int J Radiat Oncol Biol Phys. 2008;70:847–52.
Liu HH, Balter P, Tutt T, et al. Assessing respiration-induced tumor motion and internal target volume using four-dimensional computed tomography for radiotherapy of lung cancer. Int J Radiat Oncol Biol Phys. 2007;68:531–40.
Leong J. Implementation of random positioning error in computerised radiation treatment planning systems as a result of fractionation. Phys Med Biol. 1987;32:327–34.
Beckham WA, Keall PJ, Siebers JV. A fluence-convolution method to calculate radiation therapy dose distributions that incorporate random set-up error. Phys Med Biol. 2002;47:3465–73.
Chetty IJ, Rosu M, McShan DL, et al. Accounting for center-of-mass target motion using convolution methods in Monte Carlo-based dose calculations of the lung. Med Phys. 2004;31:925–32.
Keall PJ, Joshi S, Vedam SS, et al. Four-dimensional radiotherapy planning for DMLC-based respiratory motion tracking. Med Phys. 2005;32:942–51.
Rosu M, Balter JM, Chetty IJ, et al. How extensive of a 4D dataset is needed to estimate cumulative dose distribution plan evaluation metrics in conformal lung therapy? Med Phys. 2007;34:233–45.
Wolthaus JW, Schneider C, Sonke JJ, et al. Mid-ventilation CT scan construction from four-dimensional respiration-correlated CT scans for radiotherapy planning of lung cancer patients. Int J Radiat Oncol Biol Phys. 2006;65:1560–71.
Das IJ, Ding GX, Ahnesjo A. Small fields: nonequilibrium radiation dosimetry. Med Phys. 2008;35:206–15.
Reynaert N, van der Marck SC, Schaart DR, et al. Monte Carlo treatment planning for photon and electron beams. Rad Phys Chem. 2007;76:643–86.
Chetty IJ, Curran B, Cygler JE, et al. Report of the AAPM Task Group No. 105: issues associated with clinical implementation of Monte Carlo-based photon and electron external beam treatment planning. Med Phys. 2007;34:4818–53.
Mackie TR, Scrimger JW, Battista JJ. A convolution method of calculating dose for 15-MV x rays. Med Phys. 1985;12:188–96.
Timmerman RD, Paulus R, Galvin J, et al. Stereotactic body radiation therapy for medically inoperable early-stage lung cancer patients: analysis of RTOG 0236. Int J Radiat Oncol Biol Phys. 2009;75:S3.
Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancer. J Clin Oncol. 2006;24:4833–9.
Patel AH, Ajlouni M, Jin J, et al. Is stereotactic body radiotherapy (SBRT) safe for central non-small cell lung cancer (NSCLC) lesions? Int J Radiat Oncol Biol Phys. 2008;72:S434–5.
Hiraoka M, Ishikura S. A Japan clinical oncology group trial for stereotactic body radiation therapy of non-small cell lung cancer. J Thorac Oncol. 2007;2:S115–7.
Hurkmans CW, Cuijpers JP, Lagerwaard FJ, et al. Recommendations for implementing stereotactic radiotherapy in peripheral stage IA non-small cell lung cancer: report from the quality assurance working party of the randomised phase III ROSEL study. Radiat Oncol. 2009;4:1.
Harsolia A, Hugo GD, Kestin LL, et al. Dosimetric advantages of four-dimensional adaptive image-guided radiotherapy for lung tumors using online cone-beam computed tomography. Int J Radiat Oncol Biol Phys. 2008;70:582–9.
van Zwienen M, van Beek S, Belderbos J, et al. Anatomical changes during radiotherapy of lung cancer patients. Int J Radiat Oncol Biol Phys. 2008;72:S111.
Britton KR, Starkschall G, Liu H, et al. Consequences of anatomic changes and respiratory motion on radiation dose distributions in conformal radiotherapy for locally advanced non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2009;73:94–102.
Kong FM, Frey KA, Quint LE, et al. A pilot study of [18F]fluorodeoxyglucose positron emission tomography scans during and after radiation-based therapy in patients with non small-cell lung cancer. J Clin Oncol. 2007;25:3116–23.
Aerts HJ, Bosmans G, van Baardwijk AA, et al. Stability of 18F-deoxyglucose uptake locations within tumor during radiotherapy for NSCLC: a prospective study. Int J Radiat Oncol Biol Phys. 2008;71:1402–7.
Siewerdsen JH, Daly MJ, Bakhtiar B, et al. A simple, direct method for x-ray scatter estimation and correction in digital radiography and cone-beam CT. Med Phy. 2006;33:187–97.
Godfrey DJ, Ren L, Yan H, et al. Evaluation of three types of reference image data for external beam radiotherapy target localization using digital tomosynthesis (DTS). Med Phys. 2007;34:3374–84.
Ren L, Godfrey DJ, Yan H, et al. Automatic registration between reference and on-board digital tomosynthesis images for positioning verification. Med Phys. 2008;35:664–72.
Wijesooriya K, Weiss E, Dill V, et al. Quantifying the accuracy of automated structure segmentation in 4D CT images using a deformable image registration algorithm. Med Phys. 2008;35:1251–60.
Zhong H, Kim J, Chetty IJ. Analysis of deformable image registration accuracy using computational modeling. Med Phys. 2009;37:970–9.
Heath E, Seuntjens J. A direct voxel tracking method for four-dimensional Monte Carlo dose calculations in deforming anatomy. Med Phys. 2006;33:434–45.
Rosu M, Chetty IJ, Balter JM, et al. Dose reconstruction in deforming lung anatomy: dose grid size effects and clinical implications. Med Phys. 2005;32:2487–95.
Siebers JV, Zhong H. An energy transfer method for 4D Monte Carlo dose calculation. Med Phys. 2008;35:4096–105.
Kong FM, Ten Haken RK, Schipper MJ, et al. High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys. 2005;63:324–33.
Uematsu M, Shioda A, Tahara K, et al. Focal, high dose, and fractionated modified stereotactic radiation therapy for lung carcinoma patients: a preliminary experience. Cancer. 1998;82:1062–70.
Nyman J, Johansson KA, Hulten U. Stereotactic hypofractionated radiotherapy for stage I non-small cell lung cancer–mature results for medically inoperable patients. Lung Cancer. 2006;51:97–103.
Nagata Y, Takayama K, Matsuo Y, et al. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame. Int J Radiat Oncol Biol Phys. 2005;63:1427–31.
Onishi H, Shirato H, Nagata Y, et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study. J Thorac Oncol. 2007;2:S94–100.
Videtic GM, Stephans K, Reddy C, et al. Intensity-modulated radiotherapy-based stereotactic body radiotherapy for medically inoperable early-stage lung cancer: excellent local control. Int J Radiat Oncol Biol Phys. 2010;77(2):344–9. doi: 10.1016/j.ijrobp.2009.05.004. Epub 2009 Sep 18.
Fakiris AJ, McGarry RC, Yiannoutsos CT, et al. Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: four-year results of a prospective phase II study. Int J Radiat Oncol Biol Phys. 2009;75:677–82.
Baumann P, Nyman J, Lax I, et al. Factors important for efficacy of stereotactic body radiotherapy of medically inoperable stage I lung cancer. A retrospective analysis of patients treated in the Nordic countries. Acta Oncol. 2006;45:787–95.
Lagerwaard FJ, Haasbeek CJ, Smit EF, et al. Outcomes of risk-adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer. Int J Radiat Oncol Biol Phys. 2008;70:685–92.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media New York
About this entry
Cite this entry
Siddiqui, F., Chetty, I.J., Ajlouni, M., Movsas, B. (2013). Image-Guided Radiation Therapy for Lung Cancer. In: Dupuy, D., Fong, Y., McMullen, W. (eds) Image-Guided Cancer Therapy. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-0751-6_42
Download citation
DOI: https://doi.org/10.1007/978-1-4419-0751-6_42
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-0750-9
Online ISBN: 978-1-4419-0751-6
eBook Packages: MedicineReference Module Medicine